TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy DOI Creative Commons
Juan Xiao, Zhen-Wang Zhao, Fengqiao Zhou

et al.

BMC Medicine, Journal Year: 2024, Volume and Issue: 22(1)

Published: Oct. 31, 2024

Transmembrane 9 superfamily member 1 (TM9SF1) is involved in inflammation. Since both inflammatory and autoimmune diseases are linked to immune cells regulation, this study investigated the association between TM9SF1 expression disease activity. As B cell differentiation autoantibody production exacerbate disease, signaling pathways these processes were explored.

Language: Английский

Methylation across the central dogma in health and diseases: new therapeutic strategies DOI Creative Commons
Ruochen Liu, Erhu Zhao,

Huijuan Yu

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: Aug. 24, 2023

The proper transfer of genetic information from DNA to RNA protein is essential for cell-fate control, development, and health. Methylation DNA, RNAs, histones, non-histone proteins a reversible post-synthesis modification that finetunes gene expression function in diverse physiological processes. Aberrant methylation caused by mutations or environmental stimuli promotes various diseases accelerates aging, necessitating the development therapies correct disease-driver imbalance. In this Review, we summarize operating system across central dogma, which includes writers, erasers, readers, reader-independent outputs. We then discuss how dysregulation contributes neurological disorders, cancer, aging. Current small-molecule compounds target modifiers show modest success certain cancers. methylome-wide action lack specificity lead undesirable biological effects cytotoxicity, limiting their therapeutic application, especially with monogenic cause different directions changes. Emerging tools capable site-specific manipulation hold great promise solve dilemma. With refinement delivery vehicles, these new are well positioned advance basic research clinical translation field.

Language: Английский

Citations

56

Epigenetics-targeted drugs: current paradigms and future challenges DOI Creative Commons

Wanlin Dai,

Xinbo Qiao, Yuanyuan Fang

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: Nov. 26, 2024

Epigenetics governs a chromatin state regulatory system through five key mechanisms: DNA modification, histone RNA remodeling, and non-coding regulation. These mechanisms their associated enzymes convey genetic information independently of base sequences, playing essential roles in organismal development homeostasis. Conversely, disruptions epigenetic landscapes critically influence the pathogenesis various human diseases. This understanding has laid robust theoretical groundwork for developing drugs that target epigenetics-modifying pathological conditions. Over past two decades, growing array small molecule targeting such as methyltransferase, deacetylase, isocitrate dehydrogenase, enhancer zeste homolog 2, have been thoroughly investigated implemented therapeutic options, particularly oncology. Additionally, numerous epigenetics-targeted are undergoing clinical trials, offering promising prospects benefits. review delineates epigenetics physiological contexts underscores pioneering studies on discovery implementation drugs. include inhibitors, agonists, degraders, multitarget agents, aiming to identify practical challenges avenues future research. Ultimately, this aims deepen epigenetics-oriented strategies further application settings.

Language: Английский

Citations

25

Histone demethylases in the regulation of immunity and inflammation DOI Creative Commons
Lihua Qu, Tong Yin,

Yijin Zhao

et al.

Cell Death Discovery, Journal Year: 2023, Volume and Issue: 9(1)

Published: June 23, 2023

Abstract Pathogens or danger signals trigger the immune response. Moderate response activation removes pathogens and avoids excessive inflammation tissue damage. Histone demethylases (KDMs) regulate gene expression play essential roles in numerous physiological processes by removing methyl groups from lysine residues on target proteins. Abnormal of KDMs is closely associated with pathogenesis various inflammatory diseases such as liver fibrosis, lung injury, autoimmune diseases. Despite becoming exciting targets for diagnosing treating these diseases, role enzymes regulation still unclear. Here, we review underlying mechanisms through which immune-related pathways responses. In addition, also discuss future applications inhibitors

Language: Английский

Citations

29

Epigenetic Regulation of Innate and Adaptive Immune Cells in Salt-Sensitive Hypertension DOI
Ashley Pitzer Mutchler, Alexandria Porcia Haynes, Mohammad Saleem

et al.

Circulation Research, Journal Year: 2025, Volume and Issue: 136(2), P. 232 - 254

Published: Jan. 16, 2025

Access to excess dietary sodium has heightened the risk of cardiovascular diseases, particularly affecting individuals with salt sensitivity blood pressure. Our research indicates that innate antigen-presenting immune cells contribute rapid pressure increases in response intake. Emerging evidence suggests epigenetic reprogramming, subsequent transcriptional and metabolic changes, allows these have a sustained repetitive stimuli. Epigenetic mechanisms also steer T-cell differentiation signaling. Immune respond environmental nutritional cues, such as salt, promoting regulation changes. This article aims identify discuss role system contributing salt-sensitive hypertension.

Language: Английский

Citations

1

TCL1A in naïve B cells as a therapeutic target for type 1 diabetes DOI Creative Commons
Siweier Luo, Lína Zhang,

Chunfang Wei

et al.

EBioMedicine, Journal Year: 2025, Volume and Issue: 113, P. 105593 - 105593

Published: Feb. 12, 2025

Language: Английский

Citations

1

Epigenetic biomarkers for disease susceptibility and preventative medicine DOI Creative Commons
Michael K. Skinner

Cell Metabolism, Journal Year: 2024, Volume and Issue: 36(2), P. 263 - 277

Published: Jan. 3, 2024

Language: Английский

Citations

8

Metabolic imbalance driving immune cell phenotype switching in autoimmune disorders: Tipping the balance of T‐ and B‐cell interactions DOI Creative Commons
Matteo Barberis, Alejandra Rojas López

Clinical and Translational Medicine, Journal Year: 2024, Volume and Issue: 14(3)

Published: March 1, 2024

The interplay between the immune system and metabolic state of a cell is intricate. In all phases an response, corresponding changes shall occur to support its modulation, in addition signalling through cytokine environment receptor stimulation. While autoimmune disorders may develop because imbalance that modulates switching T-cell phenotypes, effects interaction T B cells have on one another's cellular metabolism are yet be understood disease context. Here, we propose perspective which highlights potential targeting modulate T- B-cell subtypes populations as well T-B B-T interactions successfully treat disorders. Specifically, envision how can tip balance interactions, definite mechanisms both health disease, explain phenotype switches cells. Within this scenario, highlight link inflammation, immunometabolism, epigenetics ageing, critical understand inflammatory combination treatments cause (T/B) imbalances, pathways involved, increase effectiveness treatment disorders, and/or ameliorate their symptoms improve patients' quality life.

Language: Английский

Citations

7

Modern concept of autoimmunity in rheumatology DOI Creative Commons
Е. Л. Насонов

Rheumatology Science and Practice, Journal Year: 2023, Volume and Issue: 61(4), P. 397 - 420

Published: Aug. 31, 2023

Two fundamental pathologic processes are central to the spectrum of chronic inflammation mechanisms: autoimmunity and autoinflammation. Autoimmunity autoinflammation mutually potent processes; their development is considered within framework “immunoinflammatory” continuum, reflecting close relationship between innate acquired types immune response. leading mechanism pathogenesis a large group inflammatory human diseases, defined as autoimmune frequency which in population exceeds 10%. Advances molecular biology, pharmacogenetics bioinformatics have created prerequisites for individualization therapy rheumatic diseases concept personalized medicine. The study immunopathogenesis mechanisms, improvement diagnostics, deciphering nature taxonomy, approaches prevention among priority directions medicine 21st century.

Language: Английский

Citations

16

Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review DOI Creative Commons
Sagnik Nag, Oishi Mitra, G. Tripathi

et al.

Immunity Inflammation and Disease, Journal Year: 2023, Volume and Issue: 11(12)

Published: Dec. 1, 2023

Abstract Background Autoimmune diseases (AD) are severe pathophysiological ailments that stimulated by an exaggerated immunogenic response towards self‐antigens, which can cause systemic or site‐specific organ damage. An array of complex genetic and epigenetic facets majorly contributes to the progression AD, thus providing significant insight into regulatory mechanism microRNA (miRNA). miRNAs short, non‐coding RNAs have been identified as essential contributors post‐transcriptional regulation host genome expression crucial regulators a myriad biological processes such immune homeostasis, T helper cell differentiation, central peripheral tolerance, development. Aims This article tends deliberate conceptualize brief pathogenesis pertinent well miRNA networks affecting five different ADs namely rheumatoid arthritis (RA), type 1 diabetes, multiple sclerosis (MS), lupus erythematosus (SLE) inflammatory bowel disorder (IBD) thereby novel miRNA‐based theranostic interventions. Results & Discussion Pertaining differential attributed in target tissues cellular bodies innate adaptive immunity, paradigm scientific expeditions suggests optimistic correlation between dysfunction alterations. Conclusion Therefore, it is not astonishing dysregulations patterns now recognized wide spectrum disorders, establishing themselves potential biomarkers therapeutic targets. Owing its potencies, targets widely utilized development biosensors other molecules originating from same.

Language: Английский

Citations

15

Targeted therapy for multiple myeloma: an overview on CD138-based strategies DOI Creative Commons
Federico Riccardi, Carmela Tangredi, Michele Dal Bo

et al.

Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14

Published: April 9, 2024

Multiple myeloma (MM) is an incurable hematological disease characterized by the uncontrolled growth of plasma cells primarily in bone marrow. Although its treatment consists administration combined therapy regimens mainly based on immunomodulators and proteosome inhibitors, MM remains incurable, most patients suffer from relapsed/refractory with poor prognosis survival. The robust results achieved immunotherapy targeting MM-associated antigens CD38 CD319 (also known as SLAMF7) have drawn attention to development new immune-based strategies different innovative compounds MM, including monoclonal antibodies, antibody-drug conjugates, recombinant proteins, synthetic peptides, adaptive cellular therapies. In this context, Syndecan1 (CD138 or SDC1), a transmembrane heparan sulfate proteoglycan that upregulated malignant cells, has gained increasing panorama target antigens, since key role tumorigenesis, progression aggressiveness been largely reported. Here, our aim provide overview important aspects investigate molecular functions CD138 physiologic cell states. addition, we will shed light CD138-based therapeutic approaches currently being tested preclinical and/or clinical phases discuss their properties, mechanisms action applications.

Language: Английский

Citations

4